Developing a Digital Aid to Improve ICD Decisions
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Stanford University
- Study ID
- NCT07084142
- Status
- Recruiting
Conditions
- Heart Failure and Reduced Ejection Fraction
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Online, patient-facing decision-making aid (app) with personalized risk information. — OTHERThe online, patient-facing decision-making aid will have the following features: 1. Clinical Data Input, 2. Introduction via Animated Video, 3. Common Questions, 4. Check-In Quiz, 5. Risk and Values Exploration based on patient specific information, 6. Wrap-Up, 7. Patient-Physician Worksheet, These steps will be completed by the patient in advance of a provider visit where a shared-decision making process will decide whether an ICD is an appropriate sudden cardiac death-prevention strategy to pursue.
- Implantable Cardioverter Defibrillator (ICD) — DEVICESome participants, in their course of medical care unrelated to the study intervention, will undergo implantation of an ICD.
- Online, patient-facing decision-making app without personalized risk information. — OTHERThe online, patient-facing decision-making aid will have the following features: 1) Clinical Data Input, 2) Introduction via Animated Video, 3) Common Questions, 4) Check-In Quiz, 5) Generic Risk and Values Exploration without patient specific information, 6) Wrap-Up, 7) Patient-Physician Worksheet, These steps will be completed by the patient in advance of a provider visit where a shared-decision making process will decide whether an ICD is an appropriate sudden cardiac death-prevention strategy to pursue.
Study Details
Advanced heart failure, affecting 7 million Americans, has multiple causes and results in greatly increased risk of disability and death. A major problem is sudden cardiac death, when the damaged heart develops an abnormal pattern of electrical conduction that can result in cessation of heart activity. While placement of an Implantable Cardioverter-Defibrillator (ICD) in a patient's chest can help prevent sudden cardiac death, these devices have several important downsides. This protocol focuses on development of a digital decision aid that helps heart failure patients make informed decisions that balance the benefits and downsides of ICD placement. This protocol covers the use of participant surveys, focus groups, and interviews to obtain the needed background information to guide the development of this digital tool, which will be subsequently tested against usual care in a randomized clinical trial. The study design is best described as a mixed methods evaluation and refinement of a digital app to improve ICD decision-making. In the future, the present protocol will be modified to create a new protocol that covers the needed human subjects requirements for performance of this clinical trial.
Key Dates
- Start date
- Aug 1, 2025
- Status verified
- Apr 2026
- Primary completion
- Aug 31, 2026
- Completion
- Feb 29, 2028
Study Design
- Enrollment
- 600 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Exposure to digital decision-making app with personal risk informationThe participant will use the pre-visit, participant-facing app with personal risk information derived from participant characteristics. During a clinical encounter, the clinician will have access to an abbreviated clinician-facing digital tool that displays the same personalized information.
- Experimental: Use of a digital decision-making app without personalized risk information.The participant will use the pre-visit, participant-facing app without personal risk information. During a clinical encounter, the clinician will have access to an abbreviated clinician-facing digital tool.
- Placebo Comparator: Usual clinical careParticipant will receive usual clinical care without use of the digital decision-making app.
Primary Outcome Measure
Decisional Conflict Scale (DCS) [ Time Frame: Immediately after decision-making visit as well as at 3 months. ]
Central Contacts
- Randall S Stafford, MD, PhD, MHS650-724-2400
- Darlyne Esparza
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | Daniel P Morin, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Eastern Carolina University | Greenville | North Carolina | 27858 | Samuel Sears, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
Related Studies
- Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic ResonanceRecruiting · Minneapolis Heart Institute Foundation · Minneapolis, Minnesota
- Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart FailureNot Yet Recruiting · Kaiser Permanente · Pleasanton, California
- Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart FailureRecruiting · Impulse Dynamics · Marlton, New Jersey